[go: up one dir, main page]

HK41792A - Medicaments for the treatment of emesis - Google Patents

Medicaments for the treatment of emesis

Info

Publication number
HK41792A
HK41792A HK417/92A HK41792A HK41792A HK 41792 A HK41792 A HK 41792A HK 417/92 A HK417/92 A HK 417/92A HK 41792 A HK41792 A HK 41792A HK 41792 A HK41792 A HK 41792A
Authority
HK
Hong Kong
Prior art keywords
emesis
medicaments
treatment
Prior art date
Application number
HK417/92A
Other languages
English (en)
Inventor
Michael Brian Tyers
Teresa Elizabeth Challoner
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10632894&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK41792(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HK41792A publication Critical patent/HK41792A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK417/92A 1988-03-04 1992-06-11 Medicaments for the treatment of emesis HK41792A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888805269A GB8805269D0 (en) 1988-03-04 1988-03-04 Medicaments

Publications (1)

Publication Number Publication Date
HK41792A true HK41792A (en) 1992-06-19

Family

ID=10632894

Family Applications (1)

Application Number Title Priority Date Filing Date
HK417/92A HK41792A (en) 1988-03-04 1992-06-11 Medicaments for the treatment of emesis

Country Status (23)

Country Link
US (2) US6544550B1 (xx)
JP (1) JPH0296525A (xx)
KR (1) KR890014109A (xx)
AT (1) AT400301B (xx)
AU (1) AU626010B2 (xx)
BE (1) BE1002255A5 (xx)
CA (1) CA1319323C (xx)
CH (1) CH678149A5 (xx)
CY (1) CY1634A (xx)
CZ (1) CZ402391A3 (xx)
DE (1) DE3906883C2 (xx)
DK (1) DK175428B1 (xx)
FR (1) FR2627986B1 (xx)
GB (2) GB8805269D0 (xx)
HK (1) HK41792A (xx)
IE (1) IE61516B1 (xx)
IT (1) IT1232662B (xx)
NL (1) NL194463C (xx)
NZ (1) NZ228214A (xx)
SE (1) SE508342C2 (xx)
SG (1) SG9092G (xx)
SK (1) SK402391A3 (xx)
ZA (1) ZA891639B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9101221D0 (en) * 1991-01-19 1991-02-27 Smithkline Beecham Plc Pharmaceuticals
US5929059A (en) * 1991-01-19 1999-07-27 Smithkline Beecham P.L.C. Pharmaceutical compositions containing granisetron and dexamethasone
EP0916346A3 (en) * 1991-09-20 2000-12-06 Glaxo Group Limited NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
US5607938A (en) * 1993-03-08 1997-03-04 Fujisawa Pharmaceutical Co., Ltd. Medicament for treating or preventing cerebrovascular infarction
US5661142A (en) * 1996-04-17 1997-08-26 Naeger; David M. Anti-emetic composition
WO2005108392A2 (en) * 2004-05-07 2005-11-17 Taro Pharmaceutical Industries Ltd. Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
US20050277624A1 (en) * 2004-06-09 2005-12-15 Nigel Cook Use of corticosteroids alone or in conjunction with nutritional therapy to reduce stress in animals
US20060263421A1 (en) * 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI84349C (fi) * 1984-01-25 1991-11-25 Glaxo Group Ltd Foerfarande foer framstaellning av en farmakologiskt vaerdefull foerening.
EP0191562B1 (en) * 1985-01-23 1991-07-10 Glaxo Group Limited Tetrahydrocarbazolone derivatives
DE201165T1 (de) * 1985-03-14 1989-04-20 Beecham Group P.L.C., Brentford Arzneimittel zur behandlung von emesis, anxietas und "irritable bowel syndrome".
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8628475D0 (en) * 1986-11-28 1987-01-07 Glaxo Group Ltd Medicaments
ES2052585T3 (es) * 1986-12-17 1994-07-16 Glaxo Group Ltd Uso de derivados cetonicos en el tratamiento de desordenes cognitivos.
US4920219A (en) * 1988-11-29 1990-04-24 Rorer Pharmaceutical Corp. Substituted saturated and unsaturated indole quinoline and benzazepine carboxamides and their use as pharmacological agents
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
US5246709A (en) * 1990-09-10 1993-09-21 Alza Corporation Antiemetic therapy

Also Published As

Publication number Publication date
CH678149A5 (xx) 1991-08-15
SE508342C2 (sv) 1998-09-28
IT8947713A0 (it) 1989-03-03
DK104389D0 (da) 1989-03-03
KR890014109A (ko) 1989-10-21
ZA891639B (en) 1990-03-28
US5482716A (en) 1996-01-09
AU3097689A (en) 1989-09-07
SK402391A3 (en) 2000-12-11
ATA48389A (de) 1995-04-15
BE1002255A5 (fr) 1990-11-06
GB8805269D0 (en) 1988-04-07
FR2627986B1 (fr) 1994-03-04
GB8904881D0 (en) 1989-04-12
GB2216414A (en) 1989-10-11
IE890697L (en) 1989-09-04
DE3906883C2 (de) 1998-11-05
AT400301B (de) 1995-12-27
GB2216414B (en) 1991-12-11
JPH0296525A (ja) 1990-04-09
NL194463B (nl) 2002-01-02
FR2627986A1 (fr) 1989-09-08
SE8900751L (sv) 1989-09-05
NL8900526A (nl) 1989-10-02
IT1232662B (it) 1992-03-02
US6544550B1 (en) 2003-04-08
DE3906883A1 (de) 1989-09-14
SE8900751D0 (sv) 1989-03-03
AU626010B2 (en) 1992-07-23
NL194463C (nl) 2002-05-03
DK175428B1 (da) 2004-10-18
SG9092G (en) 1992-03-20
DK104389A (da) 1989-09-05
CA1319323C (en) 1993-06-22
NZ228214A (en) 1997-02-24
CY1634A (en) 1992-11-06
CZ402391A3 (en) 1993-04-14
IE61516B1 (en) 1994-11-16

Similar Documents

Publication Publication Date Title
CY1727A (en) Medicaments for the treatment of emesis
AP8900136A0 (en) Medicaments
GB2220352B (en) Medicaments for the treatment of emesis
GB2216414B (en) Medicaments for the treatment of emesis
GR890100571A (en) Disposition for the treatment of seeds
GB8805268D0 (en) Medicaments
GB8814726D0 (en) Medicaments
ZA896675B (en) Medicaments
GB8808599D0 (en) Medicaments
GB8820650D0 (en) Medicaments
GB8820653D0 (en) Medicaments
IE883710L (en) Medicaments for the treatment of anxiety
GR3003007T3 (en) Process for the treatment of alpha-calciumsulphate-hemihydrate
KR0149275B1 (en) Medicaments for the treatment of cerebral apoplexy
GB8803261D0 (en) Compounds & treatment
GB8821225D0 (en) Compounds & treatment
RO101041B1 (en) Reno-urinary affections treatment medication
GB8804106D0 (en) Medicaments
GB8814054D0 (en) Medicaments
GB8826394D0 (en) Medicaments
GB8804109D0 (en) Medicaments
GB8825392D0 (en) Medicaments
GB8804110D0 (en) Medicaments
GB8819708D0 (en) Medicaments
GB8819707D0 (en) Medicaments

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20090302